List of Figures:
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. Asia Pacific Digital PCR Market, 2021-2031, $ mn 19
Figure 5. Impact of COVID-19 on Business 22
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Digital PCR Market 24
Figure 7. Leading Causes of Death in the World, 2019-2020, million 27
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 28
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 28
Figure 10. Primary Restraints and Impact Factors of Asia Pacific Digital PCR Market 30
Figure 11. Investment Opportunity Analysis 34
Figure 12. Porter’s Fiver Forces Analysis of Asia Pacific Digital PCR Market 37
Figure 13. Breakdown of Asia Pacific Digital PCR Market by Offering, 2021-2031, % of Revenue 42
Figure 14. Asia Pacific Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%) 42
Figure 15. Asia Pacific Digital PCR Market by Offering: Instruments & Accessories, 2021-2031, $ mn 43
Figure 16. Asia Pacific Digital PCR Market by Offering: Reagents & Consumables, 2021-2031, $ mn 44
Figure 17. Asia Pacific Digital PCR Market by Offering: Software & Services, 2021-2031, $ mn 45
Figure 18. Breakdown of Asia Pacific Digital PCR Market by Technology, 2021-2031, % of Sales Revenue 47
Figure 19. Asia Pacific Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%) 47
Figure 20. Asia Pacific Digital PCR Market by Technology: Droplet Digital PCR, 2021-2031, $ mn 48
Figure 21. Asia Pacific Digital PCR Market by Technology: Chip-based Digital PCR, 2021-2031, $ mn 49
Figure 22. Asia Pacific Digital PCR Market by Technology: Beaming Digital PCR, 2021-2031, $ mn 50
Figure 23. Asia Pacific Digital PCR Market by Technology: Other Technologies, 2021-2031, $ mn 51
Figure 24. Breakdown of Asia Pacific Digital PCR Market by Application, 2021-2031, % of Sales Revenue 53
Figure 25. Asia Pacific Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 53
Figure 26. Asia Pacific Digital PCR Market by Application: Research, 2021-2031, $ mn 54
Figure 27. Asia Pacific Digital PCR Market by Application: Clinical Diagnostics, 2021-2031, $ mn 55
Figure 28. Asia Pacific Digital PCR Market by Clinical Diagnostics: Infectious diseases, 2021-2031, $ mn 57
Figure 29. Asia Pacific Digital PCR Market by Clinical Diagnostics: Oncology, 2021-2031, $ mn 58
Figure 30. Asia Pacific Digital PCR Market by Clinical Diagnostics: Genetic Disorders, 2021-2031, $ mn 59
Figure 31. Asia Pacific Digital PCR Market by Clinical Diagnostics: Other Indications, 2021-2031, $ mn 60
Figure 32. Asia Pacific Digital PCR Market by Application: Forensic Testing, 2021-2031, $ mn 61
Figure 33. Asia Pacific Digital PCR Market by Application: Food and Agriculture, 2021-2031, $ mn 62
Figure 34. Asia Pacific Digital PCR Market by Application: Other Applications, 2021-2031, $ mn 63
Figure 35. Breakdown of Asia Pacific Digital PCR Market by End User, 2021-2031, % of Revenue 65
Figure 36. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 65
Figure 37. Asia Pacific Digital PCR Market by End User: Hospitals and Clinics, 2021-2031, $ mn 66
Figure 38. Asia Pacific Digital PCR Market by End User: Pharma & Biotech Companies, 2021-2031, $ mn 67
Figure 39. Asia Pacific Digital PCR Market by End User: Diagnostic Centers, 2021-2031, $ mn 68
Figure 40. Asia Pacific Digital PCR Market by End User: Other End Users, 2021-2031, $ mn 69
Figure 41. Breakdown of APAC Digital PCR Market by Country, 2021 and 2031, % of Revenue 71
Figure 42. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 72
Figure 43. Digital PCR Market in Japan, 2021-2031, $ mn 74
Figure 44. Digital PCR Market in China, 2021-2031, $ mn 76
Figure 45. Digital PCR Market in Australia, 2021-2031, $ mn 79
Figure 46. Digital PCR Market in India, 2021-2031, $ mn 81
Figure 47. Digital PCR Market in South Korea, 2021-2031, $ mn 83
Figure 48. Digital PCR Market in Rest of APAC, 2021-2031, $ mn 85
Figure 49. Growth Stage of Asia Pacific Digital PCR Industry over the Forecast Period 87
Asia Pacific digital PCR (dPCR) market will grow by 15.2% annually with a total addressable market cap of $1,699.2 million over 2022-2031, driven by the rise in prevalence of infectious diseases and cancer, growing awareness & acceptance of personalized medicines, technological advancements in diagnostic tools, and continuous increase in funding for R&D activities. Highlighted with 29 tables and 49 figures, this 104-page report “Asia Pacific Digital PCR (dPCR) Market 2021-2031 by Offering (Instruments & Accessories, Reagents & Consumables, Software & Services), Technology (Droplet, Chip-based, Beaming, Others), Application (Research, Clinical Diagnostics, Forensic, Food and Agriculture, Others), End User (Hospitals and Clinics, Pharma & Biotech Companies, Diagnostic Centers, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific digital PCR (dPCR) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific digital PCR (dPCR) market in every aspect of the classification from perspectives of Offering, Technology, Application, End User, and Country. Based on Offering, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Instruments & Accessories • Reagents & Consumables • Software & Services Based on Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Droplet Digital PCR • Chip-based Digital PCR • Beaming Digital PCR • Other Technologies By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Research • Clinical Diagnostics o Infectious diseases o Oncology o Genetic Disorders o Other Indications • Forensic Testing • Food and Agriculture • Other Applications By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals and Clinics • Pharma & Biotech Companies • Diagnostic Centers • Other End Users Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Offering, Technology, and Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: 4basebio AG Bio-Rad Laboratories, Inc. Combinati, Inc. Fluidigm Corporation Formulatrix Inc. JN Medsys Merck KGaA Qiagen N.V RainDance Technologies Stilla Technologies Inc. Sysmex Corporation Thermo Fisher Scientific, Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More